Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

21st-May-2020 08:39Source: BSE

Dr Reddys Laboratories - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group (MUFG)

Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2020-07-29

Quarterly Results

Sections